These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9660844)

  • 1. Reversible fatty acid conjugation of budesonide. Novel mechanism for prolonged retention of topically applied steroid in airway tissue.
    Miller-Larsson A; Mattsson H; Hjertberg E; Dahlbäck M; Tunek A; Brattsand R
    Drug Metab Dispos; 1998 Jul; 26(7):623-30. PubMed ID: 9660844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Budesonide fatty-acid esterification: a novel mechanism prolonging binding to airway tissue. Review of available data.
    Edsbäcker S; Brattsand R
    Ann Allergy Asthma Immunol; 2002 Jun; 88(6):609-16. PubMed ID: 12086369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic importance of the reversible fatty acid conjugation of budesonide studied in a rat cell line In vitro.
    Wieslander E; Delander EL; Järkelid L; Hjertberg E; Tunek A; Brattsand R
    Am J Respir Cell Mol Biol; 1998 Sep; 19(3):477-84. PubMed ID: 9730876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of budesonide and its major ester metabolite after inhalation and intravenous administration of budesonide in the rat.
    Jendbro M; Johansson CJ; Strandberg P; Falk-Nilsson H; Edsbäcker S
    Drug Metab Dispos; 2001 May; 29(5):769-76. PubMed ID: 11302946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [An evaluation of the acceptance of budesonide turbuhaler by older Japanese patients with bronchial asthma when changed from fluticasone propionate (FP) or beclomethasone dipropionate (BDP)].
    Ohbayashi H; Yamase H
    Arerugi; 2003 Jan; 52(1):31-8. PubMed ID: 12598720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of butixocort 21-propionate, budesonide, and beclomethasone dipropionate in the rat after intratracheal, intravenous, and oral treatments.
    Chanoine F; Grenot C; Heidmann P; Junien JL
    Drug Metab Dispos; 1991; 19(2):546-53. PubMed ID: 1676668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in endogenous esterification and retention in the rat trachea between budesonide and ciclesonide active metabolite.
    Lexmüller K; Gullstrand H; Axelsson BO; Sjölin P; Korn SH; Silberstein DS; Miller-Larsson A
    Drug Metab Dispos; 2007 Oct; 35(10):1788-96. PubMed ID: 17627977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro metabolism of beclomethasone dipropionate, budesonide, ciclesonide, and fluticasone propionate in human lung precision-cut tissue slices.
    Nave R; Fisher R; McCracken N
    Respir Res; 2007 Sep; 8(1):65. PubMed ID: 17883839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged airway activity and improved selectivity of budesonide possibly due to esterification.
    Miller-Larsson A; Jansson P; Runström A; Brattsand R
    Am J Respir Crit Care Med; 2000 Oct; 162(4 Pt 1):1455-61. PubMed ID: 11029361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The small airway inflammation of asthmatic patients who have used dry powder type inhaled steroid for moderate-long term evaluated by induced sputum and the efficacy of HFA-BDP (QVAR) inhalation].
    Ohbayashi H
    Arerugi; 2005 Jan; 54(1):24-35. PubMed ID: 15841673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effectiveness and safety of fluticasone propionate in therapy of children suffering from asthma. Part I. Mechanisms of actions and clinical effectiveness of treatment in children with asthma].
    Bartkowiak-Emeryk M; Breborowicz A; Emeryk A; Kulus M; Kurzawa R; Lis G; Mazurek H; Niedziela M
    Pol Merkur Lekarski; 2004; 17 Suppl 2():5-10. PubMed ID: 15688663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversible formation of fatty acid esters of budesonide, an antiasthma glucocorticoid, in human lung and liver microsomes.
    Tunek A; Sjödin K; Hallström G
    Drug Metab Dispos; 1997 Nov; 25(11):1311-7. PubMed ID: 9351909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of intracellular esterification in budesonide once-daily dosing and airway selectivity.
    Brattsand R; Miller-Larsson A
    Clin Ther; 2003; 25 Suppl C():C28-41. PubMed ID: 14642802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of in vitro-activity of commonly used topical glucocorticoids on cytokine- and phospholipase inhibition.
    Juergens UR; Jäger F; Darlath W; Stöber M; Vetter H; Gillissen A
    Eur J Med Res; 2004 Aug; 9(8):383-90. PubMed ID: 15337628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of clinical efficacy of inhaled glucocorticoids.
    Rohdewald PJ
    Arzneimittelforschung; 1998 Aug; 48(8):789-96. PubMed ID: 9748704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beclomethasone dipropionate versus budesonide inhalation suspension in children with mild to moderate persistent asthma.
    Terzano C; Allegra L; Barkai L; Cremonesi G
    Eur Rev Med Pharmacol Sci; 2001; 5(1):17-24. PubMed ID: 11860218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Budesonide attenuates airway remodeling and modules the expression of Janus protein tyrosine kinase 1, and signal transducers and activators of transcription 6 in asthma: an experiment with mice].
    Chen XH; Zhong NS; Zhang WD; Cao ZZ; He MZ; Luo Q; Ren XL; Li SY; L L
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(23):1627-32. PubMed ID: 17803855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extrafine beclomethasone dipropionate breath-actuated inhaler (400 micrograms/day) versus budesonide dry powder inhaler (800 micrograms/day) in asthma.
    Reichel W; Dahl R; Ringdal N; Zetterstrom O; van den Elshout FJ; Laitinen LA
    Int J Clin Pract; 2001 Mar; 55(2):100-6. PubMed ID: 11321849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The comparison of the effects of fluticasone propionate and budesonide on clinical indices and on bone mineral density in the asthmatic patients: a one year treatment study.
    Harmanci E; Ak I; Ozdemir N; Vardareli E; Elbek O; Uçgun I
    Allergol Immunopathol (Madr); 1999; 27(6):298-303. PubMed ID: 10611554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of concentrated ambient particles on normal and hypersecretory airways in rats.
    Harkema JR; Keeler G; Wagner J; Morishita M; Timm E; Hotchkiss J; Marsik F; Dvonch T; Kaminski N; Barr E
    Res Rep Health Eff Inst; 2004 Aug; (120):1-68; discussion 69-79. PubMed ID: 15543855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.